These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38709059)

  • 1. Could Cerebral Inflammatory Lesions be the Cellular Origin of Primary Central Nervous System Lymphoma?
    Ma J; Zhang J; Chen T; Bai H; Yu X; Wang H
    J Craniofac Surg; 2024 Jun; 35(4):1209-1213. PubMed ID: 38709059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ["Ghost and mimicry-tumor"--primary CNS lymphoma].
    Heckmann JG; Druschky A; Kern PM; Romstöck J; Huk W; Neundörfer B
    Nervenarzt; 2000 Apr; 71(4):305-10. PubMed ID: 10795099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose methotrexate is beneficial in parenchymal brain masses of uncertain origin suspicious for primary CNS lymphoma.
    Kiewe P; Loddenkemper C; Anagnostopoulos I; Reinwald M; Thiel E; Korfel A
    Neuro Oncol; 2007 Apr; 9(2):96-102. PubMed ID: 17301290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic red flags: steroid-treated malignant CNS lymphoma mimicking autoimmune inflammatory demyelination.
    Barrantes-Freer A; Engel AS; Rodríguez-Villagra OA; Winkler A; Bergmann M; Mawrin C; Kuempfel T; Pellkofer H; Metz I; Bleckmann A; Hernández-Durán S; Schippling S; Rushing EJ; Frank S; Glatzel M; Matschke J; Hartmann C; Reifenberger G; Müller W; Schildhaus HU; Brück W; Stadelmann C
    Brain Pathol; 2018 Mar; 28(2):225-233. PubMed ID: 28213912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing primary central nervous system lymphoma from other central nervous system diseases: a neurosurgical perspective on diagnostic dilemmas and approaches.
    Hunt MA; Jahnke K; Murillo TP; Neuwelt EA
    Neurosurg Focus; 2006 Nov; 21(5):E3. PubMed ID: 17134119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different imaging patterns of PCNSL and IVL: a case report.
    Jeon SH; Kang MK; Lee SJ; Shin BS; Kang HG
    BMC Neurol; 2019 Dec; 19(1):311. PubMed ID: 31795989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
    Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroinflammation preceding primary central nervous system lymphoma (PCNSL) - Case reports and literature review.
    Norrington M; Rathi N; Jenkinson MD; Mills SJ
    J Clin Neurosci; 2021 Jul; 89():381-388. PubMed ID: 34083111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
    Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
    Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal relapse of primary central nervous system diffuse large B-cell lymphoma: A case report.
    Ma S; Sen SS; Jug R; Zhang X; Zhang WL; Shen S; Yu CQ; Xu HT; Yang LH; Wang E
    Medicine (Baltimore); 2018 Sep; 97(38):e12482. PubMed ID: 30235749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based expert consensus on the management of primary central nervous system lymphoma in China.
    Chen T; Liu Y; Wang Y; Chang Q; Wu J; Wang Z; Geng D; Yu JT; Li Y; Li XQ; Chen H; Zhuang D; Li J; Wang B; Jiang T; Lyu L; Song Y; Qiu X; Li W; Lin S; Zhang X; Lu D; Lei J; Chen Y; Mao Y
    J Hematol Oncol; 2022 Sep; 15(1):136. PubMed ID: 36176002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory Demyelinating Lesions: True Sentinel Lesion or Immune-Mediated Response to Lymphoma?
    Qiu T; Chanchotisatien A; Qin Z; Wu J; Chu S
    World Neurosurg; 2021 Jan; 145():172-177. PubMed ID: 32949800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraocular involvement is associated with a high risk of disease relapse in primary central nervous system lymphoma.
    Zhuang L; Lai J; Chen K; Ding T; Yuan Y; Ma Y; Kang H; Lin Z; Fan N; Ma J; Zeng Q; Xu X; Wang Q; Chen B
    Oncol Rep; 2019 Jan; 41(1):397-404. PubMed ID: 30320386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory brain lesions preceding primary central nervous system lymphoma: a case report and genetic analysis.
    XiaoHong Z; Shuo Y; GeHong D; AnChao Y; Ce W; YunYun D; Can W; SiJie H; Feng C; WenBin L
    Neurol Sci; 2023 May; 44(5):1555-1561. PubMed ID: 36599976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcome.
    Adhikari N; Biswas A; Gogia A; Sahoo RK; Garg A; Nehra A; Sharma MC; Bhasker S; Singh M; Sreenivas V; Chawla R; Joshi G; Kumar L; Chander S
    J Neurooncol; 2018 Aug; 139(1):153-166. PubMed ID: 29633112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroinflammation Preceding and Accompanying Primary Central Nervous System Lymphoma: Case Study and Literature Review.
    Lu JQ; O'Kelly C; Girgis S; Emery D; Power C; Blevins G
    World Neurosurg; 2016 Apr; 88():692.e1-692.e8. PubMed ID: 26724610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of primary CNS lymphoma with high-dose methotrexate in immunocompetent pediatric patients.
    Shah AC; Kelly DR; Nabors LB; Oakes WJ; Hilliard LM; Reddy AT
    Pediatr Blood Cancer; 2010 Dec; 55(6):1227-30. PubMed ID: 20882580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of relapse after successful completion of initial therapy in primary central nervous system lymphoma: a case series.
    Patel MP; Kirkpatrick JP; Johnson MO; Healy P; Herndon JE; Lipp ES; Miller ES; Desjardins A; Randazzo D; Friedman HS; Ashley DM; Peters KB
    J Neurooncol; 2020 Apr; 147(2):477-483. PubMed ID: 32140975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination.
    Kvarta MD; Sharma D; Castellani RJ; Morales RE; Reich SG; Kimball AS; Shin RK
    BMC Neurol; 2016 May; 16():72. PubMed ID: 27206499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.